Global Non-Invasive Cancer Diagnostics Scope and Market Size
Non-Invasive Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
CTCs
CTNAS
Exosomes
Market segment by Application, split into
Blood
Urine
Saliva
Based on regional and country-level analysis, the Non-Invasive Cancer Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Non-Invasive Cancer Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 CTCs
1.2.3 CTNAS
1.2.4 Exosomes
1.3 Market by Application
1.3.1 Global Non-Invasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Blood
1.3.3 Urine
1.3.4 Saliva
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Cancer Diagnostics Market Perspective (2015-2026)
2.2 Global Non-Invasive Cancer Diagnostics Growth Trends by Regions
2.2.1 Non-Invasive Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Invasive Cancer Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Non-Invasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Invasive Cancer Diagnostics Players by Market Size
3.1.1 Global Top Non-Invasive Cancer Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Invasive Cancer Diagnostics Revenue
3.4 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Diagnostics Revenue in 2019
3.5 Key Players Non-Invasive Cancer Diagnostics Area Served
3.6 Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Non-Invasive Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Cancer Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2021-2026)
5 Non-Invasive Cancer Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Non-Invasive Cancer Diagnostics Market Size (2015-2026)
6.2 North America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
6.3 North America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
6.4 North America Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Non-Invasive Cancer Diagnostics Market Size (2015-2026)
7.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
7.4 Europe Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Non-Invasive Cancer Diagnostics Market Size (2015-2026)
8.2 China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
8.3 China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
8.4 China Non-Invasive Cancer Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Non-Invasive Cancer Diagnostics Market Size (2015-2026)
9.2 Japan Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
9.3 Japan Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
9.4 Japan Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Non-Invasive Cancer Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Details
11.1.2 Gen-Probe Inc Business Overview
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
11.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020))
11.1.5 Gen-Probe Inc Recent Development
11.2 Digene Corporation
11.2.1 Digene Corporation Company Details
11.2.2 Digene Corporation Business Overview
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
11.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.2.5 Digene Corporation Recent Development
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Details
11.3.2 Quest Diagnostics Inc Business Overview
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
11.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.3.5 Quest Diagnostics Inc Recent Development
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Details
11.4.2 Cancer, Genetics Inc Business Overview
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
11.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.4.5 Cancer, Genetics Inc Recent Development
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Details
11.5.2 BIOVIEW Inc Business Overview
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
11.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.5.5 BIOVIEW Inc Recent Development
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Details
11.6.2 AVIVA Biosciences Corporation Business Overview
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
11.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.6.5 AVIVA Biosciences Corporation Recent Development
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
11.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Details
11.8.2 A&G Pharmaceutical Business Overview
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
11.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.8.5 A&G Pharmaceutical Recent Development
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Details
11.9.2 Affymetrix Inc Business Overview
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
11.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.9.5 Affymetrix Inc Recent Development
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Details
11.10.2 Precision Therapeutics Business Overview
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
11.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.10.5 Precision Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
*If Applicable.